Interaction between Mu and Delta Opioid Receptor Agonists in an Assay of Capsaicin-Induced Thermal Allodynia in Rhesus Monkeys

Abstract EN

Delta opioid agonists enhance antinociceptive effects of mu-opioid agonists in many preclinical assays of acute nociception, but delta/mu interactions in preclinical models of inflammation-associated pain have not been examined.

This study examined interactions between the delta agonist SNC80 [(+)-4-[(αR)-α-((2S,5R)-4-allyl-2,5-dimethyl-1-piperazinyl)-3-methoxybenzyl]-N,N-diethylbenzamide] and the mu agonist analgesics methadone, morphine, and nalbuphine in an assay of capsaicin-induced thermal allodynia in rhesus monkeys.

Thermal allodynia was produced by topical application of capsaicin to the tail.

Antiallodynic effects of methadone, morphine, and nalbuphine were evaluated alone or in combination with fixed proportions of SNC80 identical to proportions previously shown to enhance acute thermal antinociceptive effects of these mu agonists in rhesus monkeys (0.9 : 1 SNC80/methadone; 0.29 : 1 SNC80/morphine; 3.6 : 1 SNC80/nalbuphine).

Methadone, morphine, and nalbuphine each produced dose-dependent antiallodynia.

SNC80 produced partial antiallodynia up to the highest dose tested (5.6 mg/kg).

SNC80 produced a modest, enantioselective, and naltrindole-reversible enhancement of methadone-induced antiallodynia.

However, SNC80 did not enhance morphine antiallodynia and only weakly enhanced nalbuphine antiallodynia.

Overall, SNC80 produced modest or no enhancement of the antiallodynic effects of the three mu agonists evaluated.

These results suggest that delta agonist-induced enhancement of mu agonist antiallodynia may be weaker and less reliable than previously demonstrated enhancement of mu agonist acute thermal nociception.